Amylin Derivatives
    1.
    发明申请
    Amylin Derivatives 失效
    淀粉酶衍生物

    公开(公告)号:US20090099085A1

    公开(公告)日:2009-04-16

    申请号:US12282042

    申请日:2007-03-15

    IPC分类号: A61K38/16 C07K14/575

    摘要: The present invention relates to novel amylin derivatives having a protracted action profile, to pharmaceutical compositions comprising these derivatives and to the use of the derivatives for the treatment of diseases related to obesity, diabetes and other metabolic disorders.

    摘要翻译: 本发明涉及具有延长作用特征的新型胰淀素衍生物,包含这些衍生物的药物组合物以及该衍生物用于治疗与肥胖症,糖尿病和其它代谢紊乱相关的疾病的用途。

    Pharmaceutically Active Insulin Receptor-Modulating Molecules
    2.
    发明申请
    Pharmaceutically Active Insulin Receptor-Modulating Molecules 审中-公开
    药学活性胰岛素受体调节分子

    公开(公告)号:US20100298213A1

    公开(公告)日:2010-11-25

    申请号:US11660846

    申请日:2005-08-19

    申请人: Lauge Schaffer

    发明人: Lauge Schaffer

    CPC分类号: A61K38/28 C07K14/72

    摘要: The invention described herein provides novel pharmaceutically active molecules (including novel peptide derivatives and peptides) that bind to an insulin receptor; compositions comprising such molecules; methods of modulating insulin receptor activity comprising the delivery of such molecules and related insulin-binding molecules (e.g., in the context of treating and/or preventing insulin receptor-related diseases such as diabetes); nucleic acids encoding such peptides; vectors and host cells comprising such nucleic acids; and methods of producing such molecules and compositions.

    摘要翻译: 本文描述的本发明提供了结合胰岛素受体的新的药物活性分子(包括新的肽衍生物和肽) 包含这种分子的组合物; 调节胰岛素受体活性的方法包括递送此类分子和相关的胰岛素结合分子(例如,在治疗和/或预防胰岛素受体相关疾病如糖尿病的情况下); 编码这些肽的核酸; 包含这种核酸的载体和宿主细胞; 以及生产这种分子和组合物的方法。

    Insulin Receptor Binding Peptides with Non-Insulin Gene Activation Profiles and Uses Thereof
    4.
    发明申请
    Insulin Receptor Binding Peptides with Non-Insulin Gene Activation Profiles and Uses Thereof 审中-公开
    胰岛素受体结合肽与非胰岛素基因激活谱及其用途

    公开(公告)号:US20090197800A1

    公开(公告)日:2009-08-06

    申请号:US11718159

    申请日:2005-10-14

    IPC分类号: A61K38/30 A61P3/10

    摘要: Methods for binding insulin receptors (and typically activating one or more function of an insulin receptor) by contacting insulin receptor-presenting cells, such as cells in a subject, with an effective amount of one or more insulin receptor binding peptides, where upregulation of one or more components of the insulin receptor-associated cholesterol synthesis pathway is not desired, are provided.

    摘要翻译: 通过将受试者中的胰岛素受体呈递细胞(例如受试者中的细胞)与有效量的一种或多种胰岛素受体结合肽接触来结合胰岛素受体(并且通常激活胰岛素受体的一种或多种功能)的方法,其中上调一种 或更多的胰岛素受体相关胆固醇合成途径的组分是不期望的。